Postpartum Depression News

In this episode, we break down the very big and very disappointing news about the failure of Biogen's closely watched experimental Alzheimer's treatment.

Postpartum depression hits low-income women especially hard. Will a promising new drug, Zulresso, become affordable and accessible enough to help them?

Good morning, Broadsheet readers! The FDA approves its first drug to treat postpartum depression, women CEOs lean less Republican than their male peers, ...

For the first time, the U.S. Food and Drug Administration has approved a drug to help women suffering with severe postpartum depression. (3/20/19) ...

Jim Cramer talks with Sage Therapeutics CEO Jeff Jonas about the biopharma company's Zulresso drug for postpartum depression and how it could help ...

An FDA study says Zulresso works differently than other antidepressants and delivers near-immediate results.

For some of the many mothers who experience postpartum depression, therapy and standard antidepressants can alleviate symptoms. But for others, those ...

A new drug approved by the Food and Drug Administration could be a game changer in treating postpartum depression.

1. Postpartum depression: There’s finally a drug for it. Too bad it’s $34,000.  Vox.com
2. F.D.A. Approves First Drug for Postpartum Depression  The New York Times
3. FDA Approves Drug That Could Help Women With Postpartum Depression  NPR
4. What we know about the FDA’s new postpartum depression drug  PBS NewsHour
5. New postpartum depression drug won't help most mothers  CNN
6. View full coverage on Google News

For most mothers a new baby is the most wonderful thing in the world. But for one in nine new mothers, that joy can be rapidly diminished by the crippling ...

A new postpartum depression drug, which was approved by the FDA on Tuesday, will be marketed as Zulresso. One Connecticut mother who participated in a ...

Host Callum Borchers speaks with former Only A Game host Bill Littlefield about the start of March Madness. Also, The first ever drug to treat postpartum ...

The first FDA-approved drug for postpartum depression costs $34000 without insurance and is delivered by infusion over 60 hours (Source: TicToc)

The first FDA-approved drug for postpartum depression costs $34000 without insurance and is delivered by infusion over 60 hours (Source: TicToc)

Approximately 1 in 9 women in the United States experiences symptoms of postpartum depression, according to the Centers for Disease Control and Prevention ...

The FDA has approved the first drug specifically developed to treat postpartum depression; a new study links frequent and high-potency marijuana use to ...

A new treatment for postpartum depression, called brexanolone, was approved by the Food and Drug Administration on Tuesday.

For the first time ever, the FDA has approved a medication specifically for treating Postpartum Depression.

For the first time ever, the FDA has approved a medication specifically for treating Postpartum Depression.

For the first time ever, the FDA has approved a medication specifically for treating Postpartum Depression.